Team find gene signature profile for metastasis

A common signature of tiny, specific pieces of non-coding genetic material known as microRNAs (miRNAs) may be directly involved in the spread of cancer to other parts of the body. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia and Ohio State University Medical Center in Columbus have identified such a signature, made up mostly of overexpressed miRNAs. The findings, reported at the annual meeting of the American Society of Clinical Oncology in Chicago, may represent a novel diagnostic tool in characterizing gene targets in metastatic cancer.

MiRNAs play a number of roles in biological regulation, including development and cell differentiation. When damaged, they can contribute to cancer by either turning on cancer-causing genes or by inhibiting tumor-blocking genes. The ways that MiRNAs are expressed have been used to profile tumor types in humans.

Because miRNAs are involved in cancer development and progression, scientists led by Raffaele Baffa, M.D., associate professor of Urology at Jefferson Medical College of Thomas Jefferson University and Anne Rosenberg, M.D., clinical professor of Surgery at Jefferson Medical College, in collaboration with a research team led by Carlo Croce, M.D., director of Ohio State University's human cancer genetics program and professor and chair of the Department of Molecular Virology, Immunology and Medical Genetics, wanted to see if there was a specific gene signature that characterized metastasis.

Usingmicroarray technology to test many genes at once, they compared different organs – breast, lung, bladder and colon – to see if miRNAs were either increased or decreased in activity. They analyzed the miRNAs in both primary and metastatic tumors from 43 patients, including 13 breast cancers, 10 lung cancers, 10 bladder urothelial cell cancers and 10 colon cancers.

They discovered that some miRNAs are organ-specific. "Some are increased and decreased specifically in certain organs, telling us that these are commonly involved in the metastatic process," says Dr. Baffa.

Because of the ups and downs in miRNA activity, "many miRNAs that are involved in metastasis are not necessarily specific for one organ, but rather are related to the cell acquiring the ability to spread." The researchers also found a direct association between the alterations in some miRNAs and changes in target proteins.

Many of the miRNAs that were overexpressed in primary tumors had previously been reported, he says, confirming that miRNA signatures are useful in classifying tissue origin.

Source: Thomas Jefferson University

Related stories:

MicroRNAs may be key to HIV's ability to hide, evade drugs
Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system. Researchers at Jefferson Medical College in Philadelphia have shown that when an individual infected with HIV receives a powerful cocktail of antiviral agents called HAART (highly active antiretroviral therapy), the virus calls on miRNAs to help it remain quiet and practically undetectable, temporarily shutting down its ability to replicate and infect.
Tiny genes may increase cancer susceptibility
New evidence indicates that small pieces of noncoding genetic material known as microRNAs (miRNAs) might influence cancer susceptibility. Differences in certain miRNAs may predispose some individuals to develop cancer, say researchers collaborating in a joint study at the Kimmel Cancer Center at Jefferson in Philadelphia, Ohio State University Medical Center in Columbus and Roswell Park Cancer Institute in Buffalo.
Scientists identify novel inhibitor of human microRNA
Scientists at The Wistar Institute and their colleagues have identified, for the first time, a molecule that can regulate microRNAs – short strands of RNA that play a vital role in gene expression and are closely associated with cancer. The discovery points the way to the development of a new generation of cancer drugs.
Researcher Discovers Molecules That Inhibit Important Gene Regulators
A North Carolina State University chemist has discovered a molecule that can potentially stop the production of cancer cells at the very beginning of the process by switching off the gene regulators responsible for turning healthy cells into cancer cells. The discovery could lead to the development of drugs that can treat some of the deadliest forms of cancer, including brain cancer.
RNA interference plays bigger role than previously thought
In a paper published today online in the journal Nature, IBM and the Genome Institute of Singapore (GIS) reported findings from a joint research study that provides new information on how stem cell differentiation is controlled by microRNAs.
Blood 'fingerprints' for cancer
Serum microRNAs (miRNAs) can serve as biomarkers for the detection of diseases including cancer and diabetes, according to research published online this week in Cell Research. The findings pave the way for a revolutionary non-invasive diagnostic tool.
Need microRNA processing? Get Smad
Researchers at Tufts University School of Medicine and Tufts Medical Center have found that Smad proteins regulate microRNA (miRNA) processing. Understanding the role of Smad proteins enables researchers to investigate abnormal miRNA processing which is a contributing factor in development of cardiovascular disorders and cancer. The study was published online today in Nature.
MicroRNA controls expression of oncogenes
A new study demonstrates that microRNAs can modulate the expression of well known tumor-specific oncogenic translocation proteins and may play a significant role in some human cancers. The research, published by Cell Press in the June issue of the journal Cancer Cell, is likely to lead to new strategies for treating some specific lymphomas and leukemias.

News discussion:

Medicine & Health news